Speciality Medicines Ltd. (SPML) Share Price Rise Streak: Stock rises 8.6%

Speciality Medicines Ltd. Share Price is trading higher in its second straight session, with the latest traded price at Rs 186.95, up 8.6%, and market capitalisation at Rs 137.5 Cr. According to latest Univest data, the price pattern is confirmed, but no company-specific catalyst is established.

For readers tracking Speciality Medicines Ltd. Share Price Rise Streak, the key point is that the move is now a two-session pattern rather than a one-day event. The cumulative rise across the streak is 19.46% from Rs 156.5, and that gives the latest Speciality Medicines Ltd. Share Price move a different context from a standalone gain. In the latest Univest figures, the company’s market capitalisation remains Rs 137.5 Cr, which helps frame the stock’s size while the second straight higher session keeps the Speciality Medicines Ltd. Share Price in focus for market participants following Speciality Medicines Ltd. Share Price Today and Speciality Medicines Ltd. Stock News.

Speciality Medicines Ltd. Share Price Rise Streak: Consecutive Gain Analysis

What matters now is not only the day move but the run itself. A second straight session higher can change how the Speciality Medicines Ltd. Share Price is read against its own recent base, even before any external explanation is established. Univest data shows the pattern clearly, and the next useful checks are price action, valuation, sector positioning and peer context.

Speciality Medicines Ltd. (SPML) rose to Rs 186.95 from the previous close of Rs 172.15, a move of Rs 14.8 or 8.6%. The stock opened at Rs 169.2, reached a high of Rs 186.95, recorded a low of Rs 169.1.

The Speciality Medicines Ltd. Share Price is trading at Rs 186.95 versus the previous close of Rs 172.15, a gain of Rs 14.80 or 8.6%. The stock opened at Rs 169.20, touched a low of Rs 169.10 and a high of Rs 186.95, which also stands as the latest traded price. That places the Speciality Medicines Ltd. Share Price at the top of the day’s range at the time of the update.

For the broader day read, the move has been firm from the opening print, but the useful point for Speciality Medicines Ltd. Share Price Today is the combination of the higher latest price and the two-session pattern. The market capitalisation is Rs 137.5 Cr, so the Speciality Medicines Ltd. Share Price is being viewed in the context of a smaller listed business rather than a broad benchmark heavyweight. As a result, the latest Speciality Medicines Ltd. Share Price Rise Streak is best read as a price action development first, with fundamentals examined next.

What the Consecutive Gains Show

The Speciality Medicines Ltd. Share Price has now risen in a second straight session, and the cumulative increase across the streak is 19.46% from Rs 156.5. That makes the current Speciality Medicines Ltd. Share Price move more relevant than a single-day rise because it compares today’s trading with yesterday’s higher base as well as the starting point of the run.

For investors tracking Speciality Medicines Ltd. Share Price Rise Streak, the important read-through is simple: the current price is being sustained above the streak base, and the second higher session confirms a continuing upward pattern in the latest Speciality Medicines Ltd. Share Price Today view. According to latest Univest data, the pattern is confirmed, but no company-specific catalyst is established. That keeps attention on valuation, sector context and peer comparison rather than on a claimed trigger for the Speciality Medicines Ltd. Share Price.

Speciality Medicines Ltd. (SPML) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 137.5 crore
P/E Ratio	11.61x
P/B Ratio	2.12x
ROE	37.85%
ROCE	34.47%
EPS	Rs 14.83
Book Value Per Share	Rs 81.03
Dividend Yield	0%

Speciality Medicines Ltd. (SPML) fundamental metrics show P/E 11.61x, P/B 2.12x, ROE 37.85%, ROCE 34.47%. These ratios show where the company stands today and are not a call to buy or sell.

Speciality Medicines Ltd. has a market capitalisation of Rs 137.5 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 11.61x, P/B at 2.12x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 37.85% and ROCE of 34.47%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 14.83, book value per share of Rs 81.03, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 22.55x, median ROE of 4.09%, median ROCE of 6.09%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Trading
Industry	Trading
Benchmark Scope	same industry
Company P/E Ratio	11.61x
Benchmark Median P/E	22.55x
Benchmark Average P/E	106.98x
Benchmark P/E Range	0.14x to 7,785.96x
Company P/B Ratio	2.12x
Benchmark Median P/B	1.38x
Company ROE	37.85%
Benchmark Median ROE	4.09%
Company ROCE	34.47%
Benchmark Median ROCE	6.09%
Company Market Capitalisation	Rs 137.5 crore
Benchmark Median Market Cap	Rs 52.73 crore

Speciality Medicines Ltd. (SPML) operates in the Trading sector, within the Trading industry.

Speciality Medicines Ltd. (SPML) has a P/E ratio of 11.61x, which is below the benchmark median of 22.55x, a difference of -48.51%. A P/E difference of this kind is a reference point rather than a recommendation.

Speciality Medicines Ltd. (SPML) has a ROE of 37.85%, which is above the benchmark median of 4.09%, a difference of +825.43%. Speciality Medicines Ltd. (SPML) has a ROCE of 34.47%, which is above the benchmark median of 6.09%, a difference of +466.01%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Adani Enterprises Ltd.	ADANIENT	3,86,893.92	51.82	4.09	15.07	13.3
ADITYA INFOTECH LIMITED	CPPLUS	48,916.5	102.13	13.86	25.68	29.48
Aegis Logistics Ltd.	AEGISLOG	47,692.13	39.17	7.43	20.71	19.76
Premier Energies Ltd.	PREMIERENE	40,310.89	24.66	8.63	42.6	33.72
Redington Ltd.	REDINGTON	32,267.74	18.65	2.99	13.6	18.96

Speciality Medicines Ltd. (SPML) has a P/E ratio of 11.61x compared with the displayed peer median of 39.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 37.85% compares with a peer median of 20.71% across the companies shown in the table. ROCE stood at 34.47% versus the displayed peer median of 19.76%, providing a capital-efficiency comparison. Speciality Medicines Ltd. (SPML) has a market capitalisation of Rs 137.5 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Speciality Medicines Ltd.

• The Speciality Medicines Ltd. Share Price is in a second straight session higher, with a 19.46% cumulative rise from Rs 156.5.
• The latest Speciality Medicines Ltd. Share Price Today is Rs 186.95, which is the session high at the time of the update.
• Valuation is still below the sector median on P/E, even after the Speciality Medicines Ltd. Share Price Rise Streak.
• ROE and ROCE remain well above the Trading sector benchmark, supporting the Speciality Medicines Ltd. Stock Performance read.
• The stock’s market capitalisation of Rs 137.5 Cr keeps the Speciality Medicines Ltd. Share Price relevant for readers comparing smaller listed names in the sector.

About Speciality Medicines Ltd.

Speciality Medicines Ltd. operates in the Trading sector and Trading industry. For a reader tracking the Speciality Medicines Ltd. Share Price, the useful business context is that the company sits within a broad trading universe rather than a narrow niche. That matters because the latest Speciality Medicines Ltd. Share Price Rise Streak should be interpreted through valuation and return ratios, not through a long operating history provided in the market view.

The company’s Speciality Medicines Ltd. Share Price is therefore best understood alongside market capitalisation, P/E, P/B, ROE, ROCE, EPS and book value. Those figures help explain why the stock is being tracked in Speciality Medicines Ltd. Stock News and Speciality Medicines Ltd. Latest News searches today, even without a confirmed company-specific trigger. In the Trading sector, the Speciality Medicines Ltd. Share Price is now being watched as a price-led event with a visible benchmark backdrop.

Frequently Asked Questions

Why is Speciality Medicines Ltd. Share Price rising today?

Ans. According to latest Univest data, the Speciality Medicines Ltd. Share Price is higher in a second straight session, but no company-specific catalyst is established. The stock is trading at Rs 186.95, with the streak base at Rs 156.5.

What is Speciality Medicines Ltd. Share Price today?

Ans. The latest Speciality Medicines Ltd. Share Price is Rs 186.95, up Rs 14.80 or 8.6% versus the previous close of Rs 172.15. The latest traded price also matches the day’s high.

What does the second straight session mean for the stock?

Ans. The Speciality Medicines Ltd. Share Price Rise Streak means the stock has risen in two consecutive sessions. The cumulative increase across the run is 19.46%, which gives the latest move a broader context than one day alone.

How does Speciality Medicines Ltd. compare on valuation?

Ans. The Speciality Medicines Ltd. Share Price carries a P/E of 11.61 and a P/B of 2.12. In the Trading sector benchmark, P/E is below the median of 22.55, while P/B is above the median of 1.38.

What do ROE and ROCE say about Speciality Medicines Ltd.?

Ans. The Speciality Medicines Ltd. Share Price is supported by ROE of 37.85% and ROCE of 34.47%. Both readings stand well above the Trading sector medians of 4.09% and 6.09%, respectively.

What is the market capitalisation of Speciality Medicines Ltd.?

Ans. The company’s Market Cap is Rs 137.5 Cr. In the same-industry benchmark, that is above the median market cap of Rs 52.73 Cr but below the average of Rs 1,597.32 Cr.

How do EPS and book value support the stock view?

Ans. EPS is Rs 14.83 and book value is Rs 81.03 per share. Those per-share figures help frame the Speciality Medicines Ltd. Share Price alongside its P/E and P/B, especially after the latest streak move.

Does Speciality Medicines Ltd. pay a dividend?

Ans. The dividend yield is 0. For the Speciality Medicines Ltd. Share Price, that means the current market read is being driven more by valuation and price action than by a dividend yield contribution.

Track Speciality Medicines Ltd. Share Price on Univest

Use Speciality Medicines Ltd. (SPML) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track the Speciality Medicines Ltd. Share Price on Univest for live price movement, key valuation ratios, 52-week levels and market insights. The same page also helps place the Speciality Medicines Ltd. Share Price Today in context with sector benchmarks, peer figures and company fundamentals.

For anyone following Speciality Medicines Ltd. Stock Analysis, Univest gives a single place to monitor the Speciality Medicines Ltd. Share Price, P/E, P/B, ROE, ROCE, EPS and book value as the stock continues to trade through the current Speciality Medicines Ltd. Share Price Rise Streak. That makes it useful for checking whether the present move is still aligned with the broader market read.